clopidogrel and ar c67085mx

clopidogrel has been researched along with ar c67085mx in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cattaneo, M; El-Tayeb, A; Gachet, C; Lecchi, A; Müller, CE; Ohlmann, P	1

Other Studies

1 other study(ies) available for clopidogrel and ar c67085mx

Article	Year
The platelet P2Y(12) receptor under normal and pathological conditions. Assessment with the radiolabeled selective antagonist [(3)H]PSB-0413. Purinergic signalling, 2013, Volume: 9, Issue:1 Topics: Adenosine Monophosphate; Animals; Binding, Competitive; Blood Platelets; Cell Line, Tumor; Cell Membrane; Clopidogrel; Data Interpretation, Statistical; Humans; Mice; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2X Receptor Antagonists; Radioligand Assay; Radiopharmaceuticals; Receptors, Purinergic P2Y12; Sulfhydryl Reagents; Thionucleosides; Ticlopidine	2013

Article

Year

The platelet P2Y(12) receptor under normal and pathological conditions. Assessment with the radiolabeled selective antagonist [(3)H]PSB-0413.

Purinergic signalling, 2013, Volume: 9, Issue:1

Topics: Adenosine Monophosphate; Animals; Binding, Competitive; Blood Platelets; Cell Line, Tumor; Cell Membrane; Clopidogrel; Data Interpretation, Statistical; Humans; Mice; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2X Receptor Antagonists; Radioligand Assay; Radiopharmaceuticals; Receptors, Purinergic P2Y12; Sulfhydryl Reagents; Thionucleosides; Ticlopidine

2013